A world leader in the development and integration of innovative materials and components, Saint-Gobain creates customized single-use solutions for the biopharmaceutical market. Through our unparalleled technological expertise and worldwide resources, we develop integrated solutions for critical fluid management that meet your evolving needs.
Saint-Gobain Life Sciences Completes Second of Seven Manufacturing Expansions as Part of Global Facility Expansion Program
LARGO, Fla.--(BUSINESS WIRE)--With construction just ending on its new facility in Largo, Florida, Saint-Gobain Life Sciences celebrates another significant milestone of its €70M global expansion program spanning seven manufacturing sites that will all be completed and operational through the end of 2020.
The 80,000 SF Largo, FL facility will become an additional manufacturing site of Saint-Gobain’s C-Flex® tubing, molded connections and assemblies used in fluid management for biopharmaceutical manufacturing. Saint-Gobain will continue to produce C-Flex® tubing and related product lines at its existing facilities in Clearwater, FL; Charny, France; and Bangalore, India.
November 14th, 2019
August 21st, 2019